RENAISSANCE TECHNOLOGIES LLC
Position in MIRM — Mirum Pharmaceuticals, Inc.
CIK 1037389
NEW YORK, NY
Position in MIRM
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$53,773,012
+$19,089,688 QoQ
Shares Held
582,085
+32.6% QoQ
Ownership
0.955%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MIRM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,467,670,450 across 330 Biotechnology names. MIRM ranks #12 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,726,993 | $588,750,729 | |
| 2 | INCY |
Incyte Corp
|
3,651,532 | $343,682,191 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
5,682,783 | $229,072,982 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
421,688 | $188,300,559 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
819,374 | $154,902,654 | |
| 6 | GMAB |
Genmab A/S
|
4,414,550 | $118,442,376 | |
| 7 | INVA |
Innoviva, Inc.
|
4,055,632 | $94,496,225 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
1,036,495 | $64,988,236 |
All Filings in MIRM
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $53,773,012 | 582,085 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $34,683,324 | 439,085 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $37,640,872 | 513,448 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $20,170,149 | 396,348 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $8,491,925 | 188,500 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,186,604 | 101,248 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,357,472 | 60,448 | Shares | Sole | 2024-11-13 | |
| 2023-12-31 | $1,731,288 | 58,648 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,170,920 | 68,700 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $300,092 | 11,600 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $326,672 | 13,600 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,819,350 | 93,300 | Shares | Sole | 2023-02-13 | |
| 2022-06-30 | $807,590 | 41,500 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $731,064 | 33,200 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $452,980 | 28,400 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $703,176 | 35,300 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $854,126 | 49,400 | Shares | Sole | 2021-08-13 | |
| 2020-12-31 | $749,034 | 42,900 | Shares | Sole | 2021-02-10 | |
| 2020-06-30 | $252,980 | 13,000 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||